Literature DB >> 26607016

Insulin antibodies in patients with type 2 diabetic receiving recombinant human insulin injection: A report of 12 cases.

Xiaolei Hu1, Xiaowen Ma2, Xin Wang2, Xiuli Zhao2, Xuling Xu2, Hui Gong2, Fengling Chen3, Junjie Sun4.   

Abstract

We report 12 cases of patients with type 2 diabetic receiving recombinant human insulin injection, who had uncontrolled hyperglycemia or frequent episodes of hypoglycemia, high levels of serum insulin and positive insulin antibodies. The clinical characteristics and insulin antibodies pharmacokinetics parameters were analyzed. After administration of glucocorticoids, changing insulin formulations or discontinuing the insulin and switching to oral antidiabetic agents, the level of insulin antibodies decreased and the plasma glucose restored. Thus, we recommend to identify the presence of high insulin antibodies in patients with type 2 diabetes who experience unexplained high plasma glucose or frequent reoccurrence of hypoglycemia.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26607016     DOI: 10.1016/j.ando.2015.10.004

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN: 0003-4266            Impact factor:   2.478


  5 in total

Review 1.  Exogenous insulin antibody syndrome (EIAS): a clinical syndrome associated with insulin antibodies induced by exogenous insulin in diabetic patients.

Authors:  Xiaolei Hu; Fengling Chen
Journal:  Endocr Connect       Date:  2017-12-12       Impact factor: 3.335

2.  Association of Higher Circulating Insulin Antibody with Increased Mean Amplitude Glycemic Excursion in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional, Retrospective Case-Control Study.

Authors:  Jian Zhu; Lu Yuan; Wen-Ji Ni; Yong Luo; Jian-Hua Ma
Journal:  J Diabetes Res       Date:  2019-03-18       Impact factor: 4.011

3.  Characteristics of OGTT and Correlation Between the Insulin to C-Peptide Molar Ratio, HOMA-IR, and Insulin Antibodies in T2DM Patients.

Authors:  Kai-Fang Hua; Ming-You Zhang; Yao Zhang; Bing-Jie Ren; Yan-Hui Wu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-08-09       Impact factor: 3.249

4.  Serious diabetic ketoacidosis induced by insulin allergy and anti-insulin antibody in an individual with type 2 diabetes mellitus.

Authors:  Kaio Takahashi; Takatoshi Anno; Haruka Takenouchi; Hideyuki Iwamoto; Megumi Horiya; Yukiko Kimura; Fumiko Kawasaki; Kohei Kaku; Koichi Tomoda; Hideaki Kaneto
Journal:  J Diabetes Investig       Date:  2022-05-31       Impact factor: 3.681

5.  Exogenous insulin antibody syndrome treated with plasma exchange after an incomplete response to immunosuppressive therapy.

Authors:  Yuan Zhuang; Xudong Wei; Yang Yu; Deqing Wang
Journal:  J Clin Apher       Date:  2021-05-20       Impact factor: 2.821

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.